Hospitals, by Type and Ownership, 2023 Exhibit 72: Share of Community Hospitals, by Health System Affiliation, 1993 to 2023 Exhibit 73: Hospital Mergers & Acquisitions, Total Announced Transacted Revenue, 2011 to 2025 Exhibit 74: Ten Largest Integrated Delivery Networks, by Net Patient Revenues, 2023 Exhibit 75: Hospital Operating Expenses, by Type of Expense, 2024 Exhibit 76: Prescription Drug Costs as a Percentage of Hospital Expenses, 2014 to 2024 Exhibit 77: Change in Hospital Drug Expense per Adjusted Discharge, 2020 to 2025 Exhibit 78: Total Cost of Drugs and Cost-to-Charge Ratio, Top 10 Hospitals, 2023 Exhibit 79: Number and Share of Pharmacists Employed by Hospitals, 2010 to 2024 Exhibit 80: Number of Inpatient Pharmacists and Pharmacy Technicians per 100 Occupied Hospital Beds, 2019 to 2024 Exhibit 81: Largest Group Purchasing Organizations, by Membership and Total Purchasing Volume, 2025 Exhibit 82: Hospital and Clinic Share of Oral Oncology Market, 2017 to 2024 Exhibit 83: Hospitals Perceived Barriers to Accessing Specialty Pharmacy Networks, 2020 vs
This gives you 2.5 mg/mL
Dermatol Surg 2004;30:11181123.
Efficacy and safety of tirzepatide versus placebo in overweight or obese adults without diabetes: A systematic review and meta-analysis of randomized controlled trials
These guidelines, put forth at the 2nd Diabetes Surgery Summit (DSS-II), also suggest metabolic surgery be considered in type 2 diabetic patients with a BMI of 3034.9 and inadequately controlled hyperglycemia (Rubino 2016)
